MONDAY, NOVEMBER 20, 2017

Visterra acquires license for dengue antibodies

Visterra, Inc., an antibody therapeutics developer, announced on Monday that it secured an exclusive patent license to a family of early-stage monoclonal antibodies that target dengue virus. Read More »

NanoViricides reports results of influenza drug candidate study

NanoViricides, Inc., a development stage pharmaceutical company, announced on Monday that its influenza drug candidate, FluCide, demonstrated an excellent safety profile in an initial non-good laboratory practice toxicology study. Read More »

CHP investigates confirmed human case of avian flu

The Hong Kong Department of Health's Centre for Health Protection said on Tuesday that the first confirmed human case of avian influenza, which was found in a 36-year-old woman, has triggered an investigation and follow-up actions. Read More »

Scripps scientists capture first ever detailed photo of HCV protein

Scripps Research Institute scientists recently captured the first detailed image of a crucial part of the hepatitis C virus, which may lead to the development of more effective drugs against hepatitis C infection. Read More »

President of Senegal Macky Sall encourages support of Global Fund

Macky Sall, the president of Senegal, encouraged the international community on Monday to invest in the replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria, according to UNAIDS. Read More »

CMC Biologics announces agreement on placental malaria vaccine

Malaria Read More »

Research determines malaria parasites are specific to host species

Malaria Read More »

FDA approves BD Diagnostics' novel StaphSR Assay

BD Diagnostics, a subsidiary of Becton, Dickinson and Company, announced on Tuesday that it has received approval from the U.S. Food and Drug Administration to market its BD MAX StaphSR Assay. Read More »

President Obama proclaims strong support for Global Fund

U.S. President Barack Obama proclaimed strong support on Monday for the Global Fund to Fight AIDS, Tuberculosis and Malaria, urging other countries to match the contribution made by the U.S. Read More »

Global Fund welcomes $800 million contribution from Japan

The government of Japan will contribute $800 million in the coming years to the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Global Fund announced on Tuesday. Read More »

St. Jude determines avian flu viruses are still a threat

Influenza Read More »

North Carolina HHS reports first three adult deaths from influenza

Influenza Read More »

Scientists discover protein that kills bacteria

Bacteria Read More »

Stabilization method for hemoglobin could stabilize vaccines

Hemoglobin Read More »

VaxTrac receives donation, continues work on mobile vaccine registry

VaxTrac said on Thursday that it will continue the development of new technology and expansion of mobile vaccine registry systems after receiving a $695,431 donation from the Bill & Melinda Gates Foundation. Read More »

WHO estimates 26 million lives can be saved through immunization efforts

The World Health Organization’s Coordinator for Programme and Impact Monitoring to the Department of Immunization, Vaccines and Biologicals Dr. Thomas Cherian called on Thursday for international government to improve vaccination programs to save lives. Read More »

UOSSM urges polio vaccination in Syria's opposition-controlled areas

Polio Read More »

PaxVax secures $22 million in funding for cholera vaccine

PaxVax, Inc., a Menlo Park, California-based vaccine developer, announced on Wednesday that it completed a $22 million financing round, which it will use to fund a clinical trial program for its cholera vaccine candidate. Read More »

Germany donates $800 million to Global Fund

Germany Chancellor Angela Merkel said on Tuesday that Germany would continue to support efforts to defeat AIDS, tuberculosis and malaria, and that remarkable progress has been made. Read More »

WHO Emergency Committee decides MERS-CoV is not Public Health Emergency

MERS CoV Read More »